Embecta (NASDAQ:EMBC) Stock

Embecta

Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.

Embecta Corp

Earnings

News

Guidance

WETH

WeTouch Technologies Reports FY24 Prelim. EPS $0.48; Revenue $42.3M

Truist Securities analyst Joon Lee reiterates Viking Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VKTX#NASDAQ">VKTX</a>) with a Buy and lowers the price target from $95 to $75.

Price Target

Reiteration

Analyst Ratings

VKTX

Truist Securities Reiterates Buy on Viking Therapeutics, Lowers Price Target to $75

Strategy Incorporated (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSTR#NASDAQ">MSTR</a>) announced it has acquired an additional 15,355 Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) for approximately $1.42 billion <a href="https://www.benzinga.com/markets/cryptocurrency/25/03/44438245/strategy-expands-bitcoin-war-chest-with-722-million-upsized-preferred-stock-offering">between April 21 and April 27 this year.</a>
What Happened: The company paid an average price of $92,737 per Bitcoin during the purchase period, including all associated fees and expenses, according to its latest filing with the U.S. Securities and Exchange Commission.
As of April 27, Strategy now holds a total of 553,555 BTC, purchased for an aggregate cost of $37.90 billion at an average price of $68,459 per Bitcoin.
The company also reported achieving a 13.7% yield on its Bitcoin holdings year-to-date in 2025, highlighting its growing returns as Bitcoin&#8217;s market price has risen throughout the year.
The latest Bitcoin acquisition was funded through proceeds from MicroStrategy's <a href="https://www.benzinga.com/markets/cryptocurrency/25/01/43399688/microstrategy-prices-preferred-stock-offering-at-80-per-share-seeks-563m-to-buy-bitcoin">ongoing at-the-market (ATM)</a> equity offerings, including both its common stock and preferred stock sales.
Also Read: <a href="https://www.benzinga.com/markets/cryptocurrency/25/04/45036669/bitcoin-supply-squeeze-will-drive-run-to-new-highs-bernstein">Bitcoin Supply Squeeze Will Drive Run To New Highs: Bernstein</a>
Whu It Matters: MicroStrategy remains the largest corporate holder of Bitcoin, continuing <a href="https://www.benzinga.com/markets/cryptocurrency/25/01/42870343/what-microstrategys-declining-net-asset-value-premium-really-means-for-bitcoin">its aggressive strategy</a> of using capital markets activities to expand its BTC treasury holdings.
The company&#8217;s strategy dashboard, updated regularly on its website, tracks Bitcoin purchases, holdings, and financial metrics for investors and the broader public.
Strategy's Bitcoin strategy, initiated in 2020, continues to drive its market valuation, with its stock gaining over 681% in the past year. 
The firm's inclusion in the Nasdaq 100 index has increased its visibility, attracting institutional investors. 
However, Strategy faces risks from Bitcoin's volatility and a $7.274 billion debt load, which could impact liquidity if prices decline sharply.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/04/45034209/bitcoin-could-hit-120000-in-q2-says-standard-chartereds-geoff-kendrick">Bitcoin Could Hit $120,000 In Q2, Says Standard Chartered&#8217;s Geoff Kendrick</a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$BTC

MSTR

Strategy Buys 15,355 Bitcoin For $1.42 Billion, Year-To-Date BTC Yield Hits 13.7%

Wells Fargo analyst Sarah Akers maintains Portland Gen Electric (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/POR#NYSE">POR</a>) with a Equal-Weight and lowers the price target from $46 to $44.

Wells Fargo Maintains Equal-Weight on Portland Gen Electric, Lowers Price Target to $44

As Washington cranks up <a href="https://www.benzinga.com/topic/tariffs">the tariff pressure</a>, Apple Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>) may have already played its smartest card: doubling down on India for assembly and investing deeper into U.S. component suppliers.
While the idea of building iPhones in America sounds good on paper, JPMorgan analyst Samik Chatterjee warns it's not that simple.
&#8220;The U.S. currently grapples with infrastructure and workforce limitations,&#8221; he notes &#8211; the same key ingredients that helped China become the manufacturing powerhouse it is today. Chatterjee estimates that entirely shifting iPhone assembly to the U.S. could trigger a painful 30% price increase for consumers if a 20% tariff on China is implemented.
Read Also: <a href="https://www.benzinga.com/personal-finance/25/04/45028360/if-you-invested-10k-in-apple-stock-10-years-ago-how-much-would-you-have-now">If You Invested $10K In Apple Stock 10 Years Ago, How Much Would You Have Now?</a>
<h2 class="wp-block-heading">Apple&#8217;s Best Move: Expand In India</h2>
Rather than chasing a moonshot strategy, Chatterjee believes Apple's best move is to turbocharge what it's already doing: expand in India. &#8220;Scaling further in India to address all local U.S. demand makes the most sense,&#8221; he argues, pointing to India's large skilled workforce, favorable government policies, and the ability to scale efficiently without blowing up costs.
That doesn't mean Apple will ignore the U.S. altogether. Instead, it is expected to invest more heavily in U.S.-based component makers. According to Chatterjee, this could include processors from Taiwan Semiconductor Manufacturing Co's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TSM#NYSE">TSM</a>) Arizona fabs, display glass from Corning Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GLW#NYSE">GLW</a>), and optical sensors from suppliers like Coherent Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COHR#NYSE">COHR</a>) and Lumentum Holdings Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LITE#NASDAQ">LITE</a>) &#8211; allowing Apple to meet political pressure without wrecking its margins.
<h2 class="wp-block-heading">Is The &#8216;Made-In-America&#8217; iPhone A Distant Dream?</h2>
A fully &#8216;Made-in-America&#8217; iPhone remains a distant dream. But a &#8220;Made-in-India, Powered-by-U.S.-Components&#8221; iPhone? That's the more likely—and smarter—reality as Apple looks to stay ahead in a world where geopolitics are increasingly shaping tech strategy.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/25/04/45032214/analyst-questions-apples-reported-iphone-shift-to-india-amid-china-tariff-pressures-doesnt-solve-all-the-problems">Analyst Casts Doubt On Apple&#8217;s Reported Move To Shift iPhone Production To India Amid Rising China Tariff Pressures: &#8216;Doesn&#8217;t Solve All The Problems&#8217;</a></li>
</ul>
Photo: Shutterstock

Analyst Color

Long Ideas

Tech

Trading Ideas

AAPL

COHR

LITE

Apple's India Game Plan Looks Smarter As Tariff Heat Rises - Analyst Highlights 4 Stocks That Could Benefit

Truist Securities analyst Peter Osterland maintains Minerals Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MTX#NYSE">MTX</a>) with a Buy and lowers the price target from $92 to $80.

Truist Securities Maintains Buy on Minerals Technologies, Lowers Price Target to $80

Wells Fargo analyst David Lantz maintains Valvoline (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VVV#NYSE">VVV</a>) with a Overweight and lowers the price target from $44 to $42.

Wells Fargo Maintains Overweight on Valvoline, Lowers Price Target to $42

Champions Oncology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CSBR#NASDAQ">CSBR</a>), a leader in translational oncology research, has been granted a license to use radioactive materials in preclinical studies. This approval allows in-house work utilizing a variety of clinically relevant radionuclides, significantly expanding the organization's capabilities in the development and assessment of targeted radiotherapeutics.
Through this license, Champions Oncology is now uniquely positioned to integrate under one roof radionuclide-based therapeutic testing with the most clinically relevant bank of patient derived xenograft (PDX) models.
 &nbsp;

CSBR

Champions Oncology Granted License To Use Radioactive Materials In Preclinical Studies

Stephens &amp; Co. analyst Daniel Imbro maintains Union Pacific (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNP#NYSE">UNP</a>) with a Overweight and lowers the price target from $275 to $255.

Stephens & Co. Maintains Overweight on Union Pacific, Lowers Price Target to $255

XRP (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/xrp/usd">XRP</a>) has emerged as the top conviction altcoin trade according to a new report from 10x Research, citing improving market structure, technical breakouts and upcoming catalysts including the launch of <a href="https://www.benzinga.com/markets/cryptocurrency/25/04/44984259/cme-group-to-launch-xrp-futures-in-may-how-did-xrp-price-react">XRP futures on CME Group.</a>
What Happened: According to 10x Research, while Bitcoin remains capped at the $94,000–$95,000 resistance zone, attention is beginning to shift towards select altcoins.
The report states that a 50 basis-point drop in Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) dominance would shift the tactical altcoin outperformance indicator, signaling a broader rotation into altcoins. 
Among these, XRP is highlighted as the most favorable setup.
XRP recently broke its downtrend and recorded a 600% surge in network payment volume and transaction counts over a four-day span, with 838 million XRP transferred on April 23 alone.
This development coincides with Coinbase (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COIN#NASDAQ">COIN</a>) listing XRP futures contracts on its U.S. derivatives exchange, and CME Group&#8217;s announcement to launch XRP futures on May 19, pending regulatory approval.
Also Read: <a href="https://www.benzinga.com/markets/25/04/45026968/bitcoin-fundamentally-decoupled-from-us-tech-stocks-blackrocks-jay-jacobs-says">Bitcoin Fundamentally Decoupled From US Tech Stocks, BlackRock&#8217;s Jay Jacobs Says</a>
Why It Matters: The report points out that despite Bitcoin's recent rebound, funding rates have remained near zero even as open interest has risen, suggesting continued skepticism among traders and a lack of excessive leverage.
Liquidity flows, however, are materially improving, reinforcing a bullish outlook for both Bitcoin and select altcoins.
10x Research expects XRP to move higher from the $2.27 level, targeting a rally toward $2.80, supported by technical strength and expanding institutional interest. 
It also notes that Korean retail traders, historically strong participants in XRP rallies, could re-engage as momentum builds.
The firm views the current environment as an attractive window to accumulate XRP ahead of the CME futures launch, highlighting that multiple catalysts are now aligning in its favor.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/25/04/45026851/bitcoin-etfs-see-442m-daily-inflow-as-btc-hovers-around-94-000">Bitcoin ETFs See $442M Daily Inflow As BTC Hovers Around $94,000</a></li>
</ul>
Image: Shutterstock

$USDT

$XRP

COIN

XRP Is The Top Altcoin Bet: 10x Research

Wells Fargo analyst David Lantz maintains Monro (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MNRO#NASDAQ">MNRO</a>) with a Equal-Weight and lowers the price target from $20 to $15.

MNRO

Wells Fargo Maintains Equal-Weight on Monro, Lowers Price Target to $15

NAAS

NaaS Technology Shares Resume Trading

Truist Securities analyst Mark Hughes maintains Kinsale Cap Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KNSL#NYSE">KNSL</a>) with a Buy and lowers the price target from $525 to $500.

KNSL

Truist Securities Maintains Buy on Kinsale Cap Gr, Lowers Price Target to $500

Wells Fargo analyst David Lantz maintains Carvana (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVNA#NYSE">CVNA</a>) with a Overweight and lowers the price target from $310 to $290.

CVNA

Wells Fargo Maintains Overweight on Carvana, Lowers Price Target to $290

Stephens &amp; Co. analyst Russell Gunther maintains First Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FBNC#NASDAQ">FBNC</a>) with a Overweight and raises the price target from $48 to $50.

FBNC

Stephens & Co. Maintains Overweight on First Bancorp, Raises Price Target to $50

Truist Securities analyst Richard Newitter maintains Integer Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ITGR#NYSE">ITGR</a>) with a Buy and raises the price target from $140 to $150.

ITGR

Truist Securities Maintains Buy on Integer Holdings, Raises Price Target to $150

Wells Fargo analyst Eric Luebchow initiates coverage on Smartstop Self Storage (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SMA#NYSE">SMA</a>) with a Overweight rating and announces Price Target of $38.

Initiation

Wells Fargo Initiates Coverage On Smartstop Self Storage with Overweight Rating, Announces Price Target of $38

Truist Securities analyst David Macdonald reiterates Encompass Health (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EHC#NYSE">EHC</a>) with a Buy and raises the price target from $116 to $135.

Truist Securities Reiterates Buy on Encompass Health, Raises Price Target to $135

NaaS Technology Shares Halted On Circuit Breaker To The Upside, Shares Up 9.16%

Truist Securities analyst Youssef Squali upgrades Peloton Interactive (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PTON#NASDAQ">PTON</a>) from Hold to Buy and maintains the price target from $11 to $11.

Comments

Embecta

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL